Mumbai, India – PI Health Sciences (PIHS), a leading global provider of integrated drug discovery and development solutions and a wholly owned subsidiary of PI Industries, today announced a strategic collaboration with Cresset® to implement Torx® Software, a state-of-the-art cloud-based platform for small molecule drug discovery. This partnership marks a significant step in PI Health Sciences’ commitment to driving innovation, operational excellence, and transformative solutions across the pharmaceutical value chain.

Torx Software, developed jointly by Cresset and Elixir Software, is the industry’s only comprehensive DMTA (design-make-test-analyze) platform. It empowers research teams to seamlessly coordinate molecule design, synthesis, testing, and data analysis in a single, integrated digital environment. By centralizing critical information and enabling real-time collaboration, Torx streamlines decision-making, reduces cycle times, and enhances productivity in drug discovery projects.